Skip to main content
    O

    Orthofix Medical Inc (OFIX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $6.80
    -0.37 (-5.16%)

    Market Cap: $292.25M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Orthofix Medical Inc (OFIX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Orthofix Medical reported revenue of $822.31M for the fiscal year ended Dec 31, 2025, up 2.9% from the year before. That year, net income was -$92.19M with a net margin of -11.2%, operating cash flow was $33.35M and free cash flow was -$1.28M. The quarter ended Sep 30, 2026 had revenue of $207.86M and net income of -$6.07M.

    Revenue and Margins

    The operating margin was -9.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $409.79M, a compound annual rate of 8.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$822.31M+2.9%68.8%-9.9%-11.2%
    Dec 2024$799.49M+7.1%68.3%-10.6%-15.8%
    Dec 2023$746.64M+62.1%65.1%-18.6%-20.3%
    Dec 2022$460.71M-0.8%73.2%-2.9%-4.3%
    Dec 2021$464.48M+14.2%75.3%-1.8%-8.3%
    Dec 2020$406.56M-11.6%74.9%-1.5%0.6%
    Dec 2019$459.95M+1.5%78.1%-4.1%-6.2%
    Dec 2018$453.04M+4.4%78.7%6.6%3.0%
    Dec 2017$433.82M+5.9%78.6%9.4%1.4%
    Dec 2016$409.79MN/A78.6%5.1%0.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$822.31M$799.49M$746.64M$460.71M$464.48M$406.56M$459.95M$453.04M$433.82M$409.79M
    Cost of revenue$256.30M$253.61M$260.37M$123.54M$114.91M$101.89M$100.61M$96.63M$93.04M$87.85M
    Gross profit$566.02M$545.88M$486.27M$337.17M$349.56M$304.67M$359.35M$356.41M$340.79M$321.94M
    Research and development$65.85M$73.64M$80.23M$49.06M$49.62M$39.06M$34.64M$33.22M$29.70M$28.80M
    Operating income-$81.43M-$84.62M-$139.11M-$13.27M-$8.31M-$6.27M-$18.78M$30.09M$40.81M$21.07M
    Net income-$92.19M-$126.00M-$151.40M-$19.75M-$38.38M$2.52M-$28.46M$13.81M$6.22M$3.06M
    EBITDA$9.93M-$6.09M-$43.44M$15.66M$21.44M$36.39M$1.55M$43.40M$58.64M$40.67M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$207.86M$210.93M$196.71M$219.91M$205.63M$203.12M$193.65M$215.66M$196.61M$198.62M$188.61M$200.41M
    Gross profit$146.55M$149.71M$139.55M$156.34M$148.52M$139.53M$121.62M$148.84M$135.05M$134.75M$127.24M$136.63M
    Operating income$1.54M-$8.13M-$14.44M$494.00K-$17.05M-$16.00M-$48.87M-$11.48M-$18.90M-$24.91M-$29.34M-$18.32M
    Net income-$6.07M-$15.80M-$20.91M-$2.22M-$22.80M-$14.08M-$53.09M-$29.15M-$27.39M-$33.44M-$36.02M-$22.17M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $161.38M exceeded cash and equivalents by $79.35M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$850.65M$893.29M$925.32M$458.63M$476.62M$525.86M$495.62M$466.64M$405.35M$372.10M
    Current assets$416.85M$433.29M$420.44M$255.99M$269.52M$270.38M$260.55M$244.64M$251.80M$194.37M
    Cash and equivalents$82.03M$83.24M$33.11M$50.70M$87.85M$96.29M$69.72M$69.62M$81.16M$39.57M
    Total liabilities$400.61M$390.17M$326.58M$121.77M$139.69M$169.00M$167.99M$131.24M$108.75M$108.63M
    Short-term debt$3.98M$0$1.25M$0$4.42M$2.60M$2.20M$0$0$0
    Long-term debt$157.39M$157.01M$93.11M$0N/AN/AN/A$0$0$0
    Shareholder equity$450.04M$503.12M$598.73M$336.86M$336.93M$356.86M$327.63M$335.40M$296.61M$263.48M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$855.76M$873.02M$886.60M$850.65M$832.61M$837.16M$823.14M$893.29M$867.87M$882.00M$906.05M$925.32M
    Total liabilities$426.19M$443.84M$451.42M$400.61M$390.12M$378.81M$364.85M$390.17M$341.95M$335.99M$335.74M$326.58M
    Cash and equivalents$86.32M$103.81M$120.28M$82.03M$62.86M$65.61M$57.95M$83.24M$30.05M$26.37M$26.96M$33.11M
    Shareholder equity$429.57M$429.18M$435.19M$450.04M$442.49M$458.35M$458.29M$503.12M$525.92M$546.00M$570.32M$598.73M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$33.35M$25.79M-$45.75M-$11.54M$18.48M$74.27M$32.03M$49.92M$38.97M$59.08M
    Capital expenditures$34.63M$34.88M$62.05M$23.16M$17.79M$15.48M$19.00M$13.59M$14.66M$16.43M
    Free cash flow-$1.28M-$9.09M-$107.80M-$34.70M$690.00K$58.79M$13.04M$36.33M$24.31M$42.64M
    Dividends paid$0$0$26.90M$0$0$2.49M$5.19M$0$0$0
    Share repurchasesN/AN/AN/AN/AN/AN/AN/AN/AN/A$63.42M
    Investing cash flow-$34.60M-$27.58M-$33.13M-$24.53M-$23.01M-$52.33M-$22.92M-$61.00M-$16.47M-$21.95M
    Financing cash flow-$786.00K$50.71M$65.32M-$78.00K-$3.62M$3.25M-$10.69M$2.99M$3.54M-$46.11M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$363.00K-$6.22M-$17.61M$27.70M$12.40M$11.64M-$18.39M$23.73M$11.67M$8.98M-$18.59M-$6.69M
    Capital expenditures$14.50M$12.65M$10.66M$10.88M$9.90M$7.11M$6.74M$8.53M$5.81M$9.72M$10.82M$16.36M
    Free cash flow-$14.14M-$18.87M-$28.27M$16.82M$2.50M$4.53M-$25.13M$15.20M$5.86M-$732.00K-$29.41M-$23.05M
    Last 12 quarters

    Frequently Asked Questions About OFIX

    What is Orthofix Medical's annual revenue?

    Orthofix Medical reported revenue of $822.31M for the fiscal year ended Dec 31, 2025.

    How fast is Orthofix Medical's revenue growing?

    Revenue was up 2.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 21.3%.

    Is Orthofix Medical profitable?

    No. Orthofix Medical reported net income of -$92.19M for the fiscal year ended Dec 31, 2025, with a net margin of -11.2%.

    How much free cash flow does OFIX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $33.35M minus capital expenditures of $34.63M produced free cash flow of -$1.28M.

    How much debt does Orthofix Medical have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $157.39M, short-term debt of $3.98M and cash and equivalents of $82.03M.